Thesis

Thesis is a company focused on cognitive enhancement, believing everyone can unlock their brain’s full potential. They address the challenges of keeping pace with modern life’s constant stimuli, which often leads to a lack of presence. Their solution is an ecosystem centered around nootropic blends formulated with high-quality, high-potency, bioavailable ingredients at clinically studied dosages. These blends aim to boost brain function and enhance mental clarity, helping individuals achieve their goals. Thesis has already achieved significant success, securing over $14 million in venture capital, endorsements from healthcare experts and athletes, and advisory support from leading neuroscientists at Yale, Penn, and MIT. They are actively seeking to expand their team to further revolutionize cognitive enhancement.